ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ် P53-24 MagellanRx Management, a Prime Therapeutics Company (UM) Program: Medical Drug Updates ဖးအါထီၣ် တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါအီကူာ် 01, 2024
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ် 2024 August Bulletins ဖးအါထီၣ် တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါအီကူာ် 01, 2024
ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ် P51-24 Inpatient Admission, Concurrent Review, and Discharge Submission Process Change for Commercial & Medicare Advantage Members ဖးအါထီၣ် တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲ အမုၢ်နံၤမုၢ်သီ- လါအီကူာ် 01, 2024